Humacyte Inc’s recent filing unveils that its Director Constantino Michael T. acquired Company’s shares for reported $20181.0 on Dec 04 ’24. In the deal valued at $4.39 per share,4,600 shares were bought. As a result of this transaction, Constantino Michael T. now holds 16,950 shares worth roughly $78817.5.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Niklason Laura E bought 1,797 shares, generating $7,979 in total proceeds. Upon buying the shares at $4.44, the President, CEO and Director now owns 243,851 shares.
Before that, Dougan Brady W bought 1,797 shares. Humacyte Inc shares valued at $7,979 were divested by the Director at a price of $4.44 per share. As a result of the transaction, Dougan Brady W now holds 243,851 shares, worth roughly $1.13 million.
H.C. Wainwright reiterated its Humacyte Inc [HUMA] rating to a Buy in a research note published on December 20, 2024; the price target was $15. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. Piper Sandler also remained covering HUMA and has increased its forecast on August 14, 2023 with a “Neutral” recommendation from previously “an Underweight” rating. Cantor Fitzgerald started covering the stock on June 22, 2023. It rated HUMA as “an Overweight”.
Price Performance Review of HUMA
On Monday, Humacyte Inc [NASDAQ:HUMA] saw its stock jump 0.22% to $4.65. Over the last five days, the stock has gained 7.14%. Humacyte Inc shares have risen nearly 63.73% since the year began. Nevertheless, the stocks have risen 65.48% over the past one year. While a 52-week high of $9.97 was reached on 05/31/24, a 52-week low of $2.48 was recorded on 01/17/24. SMA at 50 days reached $4.83, while 200 days put it at $5.43.
Levels Of Support And Resistance For HUMA Stock
The 24-hour chart illustrates a support level at 4.22, which if violated will result in even more drops to 3.78. On the upside, there is a resistance level at 5.03. A further resistance level may holdings at 5.40. The Relative Strength Index (RSI) on the 14-day chart is 53.66, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.03, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 62.35%. Stochastics %K at 26.81% indicates the stock is a holding.
How much short interest is there in Humacyte Inc?
A steep rise in short interest was recorded in Humacyte Inc stocks on 2024-11-29, growing by 3.08 million shares to a total of 20.33 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 17.25 million shares. There was a rise of 15.16%, which implies that there is a positive sentiment for the stock.
